Connected care company ResMed announced it will acquire MatrixCare, a provider of long-term care EHR software, for $750M to expand its out-of-hospital SaaS portfolio. Named "Best in KLAS" for long-term post-acute care software, MatrixCare’s solutions help Accountable Care Organizations, skilled nursing and senior living providers, life plan communities, and home health organizations to connect, collaborate and prosper as we migrate to a fee-for-value healthcare system. In addition to electronic
Read More
ResMed to Acquire Home Health Software Provider HEALTHCAREfirst
ResMed, a global leader in connected healthcare solutions, today announced it has entered into a definitive agreement to acquire privately held HEALTHCAREfirst, a provider of software solutions and services for home health and hospice agencies. Financial terms of the acquisition were not disclosed. Founded in 1992, HEALTHCAREfirst offers electronic health record (EHR) software, billing and coding services, and advanced analytics that enable home health and hospice agencies to optimize their
Read More
ResMed Integrates Remote Patient Monitoring Platform With AirMini CPAP Device
ResMed announced that it has added cloud-connectivity to the AirMini, the world's smallest, portable CPAP device- through its AirView platform. The connectivity between AirMini and AirView enables clinicians to see patients' nightly data, verify adherence, and spot therapy issues – giving them a great opportunity to educate and engage patients to reach the best possible health outcomes. AirMini is available in 15 countries across North America, Europe and Asia-Pacific, with more countries to
Read More
ResMed Scoops Up Home Health Software Brightree for $800M
ResMed a medical device company and innovator in sleep-disordered breathing and respiratory care has acquired business management and clinical software applications for the post-acute care Brightree for $800M in cash. This acquisition adds to ResMed's global leadership in connected healthcare solutions. Under the terms of the agreement, ResMed will fund the acquisition primarily with debt. Brightree reported net sales of approximately $113 million and EBITDA of about $43 million in 2015.
On
Read More